Is upfront full molecular profiling needed in all patients with colorectal cancer in daily practice?

Lancet Oncol. 2022 Sep;23(9):1129-1131. doi: 10.1016/S1470-2045(22)00035-3.

Authors

Rodrigo Dienstmann, Sara Lonardi

PMID: 36055302
DOI: 10.1016/S1470-2045(22)00035-3

No abstract available

MeSH terms

Colorectal Neoplasms* / drug therapy
Colorectal Neoplasms* / genetics
Humans
Retrospective Studies